You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLC Buy Disclosure
Trieu Vuong · SEC Form 4 · Filed Jun 17, 2026
Buy
Calculated transaction value
$10.69K
Trieu Vuong Chairman And CEO
OTLC
Transaction date
Jun 17, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed same day
OTLC daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 239,759 shares @ $0.04
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-029137
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$15.01K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oncotelic Therapeutics, Inc. OTLC Current | Buy | Jun 17, 2026 | $10.69K |
| Oncotelic Therapeutics, Inc. OTLC | Buy | Jun 15, 2026 | $4.32K |